GW

Genevieve Mary Weir

IT Immunovaccine Technologies: 12 patents #2 of 20Top 10%
📍 Dartmouth, CA: #5 of 146 inventorsTop 4%
Overall (All Time): #407,658 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
11717563 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance Marc Mansour, Leeladhar Sammatur, Lisa Diana MacDonald, Mohan Karkada, Antar Fuentes-Ortega 2023-08-08
11260116 Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof Marianne STANFORD, Frederic Ors, Leeladhar Sammatur 2022-03-01
11235069 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo Marc Mansour, Mohan Karkada 2022-02-01
11160861 Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant Lisa Diana MacDonald, Robert Liwski, Marc Mansour 2021-11-02
11077184 Liposome compositions comprising PAM2Cys or PAM3Cys adjuvant and methods for inducing a humoral immune response Marc Mansour, Lisa Diana MacDonald, Leeladhar Sammatur, Kendall Sharp 2021-08-03
10988500 Lipid A mimics, methods of preparation, and uses thereof Zi-Hua Jiang, Jordan David Lewicky, Rajkannan Rajagopalan, Leeladhar Sammatur, Marianne STANFORD +1 more 2021-04-27
10729766 Method for improving the efficacy of a survivin vaccine in the treatment of cancer Marc Mansour, Neil Berinstein, Marianne STANFORD 2020-08-04
10533033 Lipid A mimics, methods of preparation, and uses thereof Zi-Hua Jiang, Jordan David Lewicky, Rajkannan Rajagopalan, Leeladhar Sammatur, Marianne STANFORD +1 more 2020-01-14
10232052 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo Marc Mansour, Mohan Karkada 2019-03-19
10105435 Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof Marc Mansour, Lisa Diana MacDonald, Leeladhar Sammatur, Kendall Sharp 2018-10-23
10022441 Method for improving the efficacy of a survivin vaccine in the treatment of cancer Marc Mansour, Neil Berinstein, Marianne STANFORD 2018-07-17
9498493 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo Marc Mansour, Mohan Karkada 2016-11-22